These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32911601)

  • 61. Analyte comigrating with trisialotransferrin during capillary zone electrophoresis of sera from patients with cancer.
    Ramdani B; Nuyens V; Codden T; Perpete G; Colicis J; Lenaerts A; Henry JP; Legros FJ
    Clin Chem; 2003 Nov; 49(11):1854-64. PubMed ID: 14578317
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Differential characteristics of AMA-M2 autoantibody in primary biliary cirrhosis and non-PBC patients].
    Sun L; Wang Y; Liu Y; Zhao Y; Zhang X; Wang Y; Zhao D; Zhang H; Ma Y
    Zhonghua Gan Zang Bing Za Zhi; 2015 May; 23(5):343-9. PubMed ID: 26192239
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of carbohydrate-deficient transferrin (CDT) and gamma-glutamyl-transferase (GGT) with serum lipid profile in the Finnish population.
    Nikkari ST; Koivu TA; Kalela A; Strid N; Sundvall J; Poikolainen K; Jousilahti P; Alho H; Sillanaukee P
    Atherosclerosis; 2001 Feb; 154(2):485-92. PubMed ID: 11166783
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Metabolomic analysis of cholestatic liver damage in mice.
    Yang R; Zhao Q; Hu DD; Xiao XR; Huang JF; Li F
    Food Chem Toxicol; 2018 Oct; 120():253-260. PubMed ID: 30009888
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The gut microbial influence on cholestatic liver disease.
    Kummen M; Hov JR
    Liver Int; 2019 Jul; 39(7):1186-1196. PubMed ID: 31125502
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis?
    Nakajima M; Shimizu H; Miyazaki A; Watanabe S; Kitami N; Sato N
    J Gastroenterol; 1999 Oct; 34(5):607-12. PubMed ID: 10535489
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 68. norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
    Fickert P; Hirschfield GM; Denk G; Marschall HU; Altorjay I; Färkkilä M; Schramm C; Spengler U; Chapman R; Bergquist A; Schrumpf E; Nevens F; Trivedi P; Reiter FP; Tornai I; Halilbasic E; Greinwald R; Pröls M; Manns MP; Trauner M;
    J Hepatol; 2017 Sep; 67(3):549-558. PubMed ID: 28529147
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Plasmapheresis exerts a long-lasting antipruritic effect in severe cholestatic itch.
    Krawczyk M; Liebe R; Wasilewicz M; Wunsch E; Raszeja-Wyszomirska J; Milkiewicz P
    Liver Int; 2017 May; 37(5):743-747. PubMed ID: 27778443
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.
    Li Y; Tang R; Leung PSC; Gershwin ME; Ma X
    Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis.
    Harada K; Isse K; Kamihira T; Shimoda S; Nakanuma Y
    Hepatology; 2005 Jun; 41(6):1329-38. PubMed ID: 15880426
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Current Status of Liver Transplantation for Primary Biliary Cholangitis.
    Aguilar MT; Carey EJ
    Clin Liver Dis; 2018 Aug; 22(3):613-624. PubMed ID: 30259857
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?
    Sánchez-Pobre P; Castellano G; Colina F; Dominguez P; Rodriguez S; Canga F; Herruzo JA
    J Clin Gastroenterol; 1996 Oct; 23(3):191-8. PubMed ID: 8899500
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Real-World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis.
    Roberts SB; Ismail M; Kanagalingam G; Mason AL; Swain MG; Vincent C; Yoshida EM; Tsien C; Flemming JA; Janssen HLA; Hirschfield GM; Hansen BE; Gulamhusein AF;
    Hepatol Commun; 2020 Sep; 4(9):1332-1345. PubMed ID: 32923836
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hepatic copper content is normal in early primary biliary cirrhosis and primary sclerosing cholangitis.
    Kowdley KV; Knox TA; Kaplan MM
    Dig Dis Sci; 1994 Nov; 39(11):2416-20. PubMed ID: 7956610
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Primary Biliary Cholangitis: A Case of Underdiagnosis.
    Garcês Soares S; Mendes M; Rodrigues Carvalho S; Pereira Anjos D; Sá AJ
    Cureus; 2021 Sep; 13(9):e17716. PubMed ID: 34650890
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gamma-Glutamyl Transferase in Patients With Primary Biliary Cholangitis.
    Gerussi A
    Gastroenterol Hepatol (N Y); 2022 Dec; 18(12):706-708. PubMed ID: 36865589
    [No Abstract]   [Full Text] [Related]  

  • 78. The Association of Serum Profile of Transferrin Isoforms with COVID-19 Disease Severity.
    Chrostek L; Gan K; Kazberuk M; Kralisz M; Janicka K; Gruszewska E; Panasiuk A; Cylwik B
    J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673719
    [No Abstract]   [Full Text] [Related]  

  • 79. The Serum Profile of Transferrin Isoforms in Pancreatitis.
    Mucha A; Zaczek M; Kralisz M; Gruszewska E; Cylwik B; Panasiuk A; Chrostek L
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329964
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.